Axiostat® uses a.c.t (axio clotting technology) to control severe haemorrhage within minutes. a.c.t is based on a biopolymer platform that utilises cationic properties for medical applications. Axiostat® is a 100% chitosan dressing made from pure grade chitosan extracted from shellfish.
Chitosan is a linear polysaccharide consisting of glucosamine and N-acetyl glucosamine chains and is derived mainly from shellfish. It has been used in many technical applications such as medical products, water purification, in cosmetics and as a fat-binding weight control product. Cationic nature of chitosan gives this polymer a mucoadhesive property which can be further activated for wound care applications
Chitosan salts are used as a matrix or scaffold material as well as in non-parenteral delivery systems for challenging drugs
Chitosan has been in use for medical application since beginning of 21st century. However major challenges associated with chitosan based products are lack of consistency and presence of impurities. Axio uses a proprietary technology to filter, purify chitosan and result is end products without any variation in performance or safety features. Particularly Axio technology uses low polydispersity, high molecular weight raw material with a very pure, 100% chitosan, quick-acting Haemostat.
Axio products are constantly benchmarked with global harmonised standards and starting material, chitosan complies with the ASTM standard.and are made in ISO 13485 approved facilities.
CHARACTERISTICS OF CHITOSAN
No exothermic reaction
Easily broken down to glucosamine